Khava E. Ibragimova

Maastricht, LI 6202AZ, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry.

Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry.

Journal: Breast cancer research and treatment

Published: September 04, 2023

Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE Registry.

Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE Registry.

Journal: Clinical breast cancer

Published: April 03, 2023

Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry.

Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry.

Journal: Breast cancer research and treatment

Published: October 17, 2022

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry.

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry.

Journal: Breast cancer research and treatment

Published: October 12, 2021

Healthcare Use during the Last Six Months of Life in Patients with Advanced Breast Cancer.

Healthcare Use during the Last Six Months of Life in Patients with Advanced Breast Cancer.

Journal: Cancers

Published: September 23, 2021

Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry.

Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry.

Journal: Breast cancer research and treatment

Published: January 19, 2021

The role of chemotherapy in treatment of advanced breast cancer: an overview for clinical practice.

The role of chemotherapy in treatment of advanced breast cancer: an overview for clinical practice.

Journal: Critical reviews in oncology/hematology

Published: January 28, 2020

Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands.

Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: December 06, 2019

Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands.

Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands.

Journal: PloS one

Published: August 13, 2019

A real-life study on the implementation and effectiveness of exemestane plus everolimus per hospital type in patients with advanced breast cancer. A study of the Southeast Netherlands Advanced Breast Cancer registry.

A real-life study on the implementation and effectiveness of exemestane plus everolimus per hospital type in patients with advanced breast cancer. A study of the Southeast Netherlands Advanced Breast Cancer registry.

Journal: Breast (Edinburgh, Scotland)

Published: September 09, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026